IPKat congratulates three new IP silks

The IPKat team is delighted to hear news of three freshly-gowned members of the IP bar, who have been elevated to Queen’s Counsel in the 2019 “silk round”. In alphabetical order:

- Mark Chacksfield (8 New Square), who represented Abbvie in defending FKB’s claim for an Arrow declaration

- Lindsay Lane (8 New Square), who appeared for Teva in several generics’ successful challenge to the validity of Gilead’s SPC protecting TRUVADA.

- Brian Nicholson (11 South Square), who appeared for American Science & Engineering in a successful infringement claim and validity defence against Rapiscan Systems.

Hearty congratulations to all three, particularly as part of a smaller round than in recent years. [Merpel notes that silk prices have been in decline for the last six months, so the timing is fortuitous.]    

IPKat congratulates three new IP silks IPKat congratulates three new IP silks Reviewed by Alex Woolgar on Thursday, January 10, 2019 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Powered by Blogger.